First Eagle Investment Management’s Sanofi Contingent Value Rights GCVRZ Stock Holding History
Bought
Maintained
Sold
Other funds holding GCVRZ
SCM
EM
MCM
TGHSA
BCM
HCM
WA
FCM
GCM
NGA
First Eagle Investment Management's GCVRZ Position: Q1 2018 in Review
First Eagle Investment Management sold out of Sanofi Contingent Value Rights (GCVRZ) in Q1 2018, closing a stake of 146,402 shares — an estimated $56K sold.
First Eagle Investment Management first reported a position in GCVRZ in Q2 2013 and held it in 19 quarters. The position peaked at $116K in Q4 2014. 100 funds tracked by Wall St. Rank hold GCVRZ as of Q1 2018.
- First Eagle Investment Management reported no remaining Sanofi Contingent Value Rights position as of Q1 2018 after selling out during the quarter.
- First Eagle Investment Management sold 146,402 Sanofi Contingent Value Rights shares in Q1 2018, an estimated $56K.
- First Eagle Investment Management first reported a position in Sanofi Contingent Value Rights in Q2 2013 and held it in 19 quarters.
- First Eagle Investment Management's Sanofi Contingent Value Rights position peaked at $116K in Q4 2014.
- 100 funds tracked by Wall St. Rank held Sanofi Contingent Value Rights as of Q1 2018.
Based on First Eagle Investment Management's 13F filing for Q1 2018, filed 4 May 2018.